[1]李 清.内镜下鼓膜切开置管术治疗分泌性中耳炎的临床疗效及并发症观察[J].医学信息,2024,37(22):46-49.[doi:10.3969/j.issn.1006-1959.2024.22.011]
　LI Qing.Observation on the Clinical Efficacy and Complications of Endoscopic Tympanostomy Tube Insertion in the Treatment of Secretory Otitis Media[J].Journal of Medical Information,2024,37(22):46-49.[doi:10.3969/j.issn.1006-1959.2024.22.011]
点击复制

内镜下鼓膜切开置管术治疗分泌性中耳炎的临床疗效及并发症观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年22期
页码:
46-49
栏目:
论著
出版日期:
2024-11-15

文章信息/Info

Title:
Observation on the Clinical Efficacy and Complications of Endoscopic Tympanostomy Tube Insertion in the Treatment of Secretory Otitis Media
文章编号:
1006-1959（2024）22-0046-04
作者:
李 清
上栗县人民医院眼耳鼻喉科，江西 上栗 337009
Author(s):
LI Qing
Department of Ophthalmology,Otolaryngology,Shangli County People’s Hospital,Shangli 337009,Jiangxi,China
关键词:
分泌性中耳炎; 内镜下鼓膜切开置管术; 咽鼓管功能; 听力水平; 耳鸣症状; 并发症
Keywords:
Secretory otitis media; Endoscopic tympanic tube insertion; Eustachian tube function; Listening level; Tinnitus symptoms; Complications
分类号:
R764.9+2
DOI:
10.3969/j.issn.1006-1959.2024.22.011
摘要:
目的 研究内镜下鼓膜切开置管术（TBI）治疗分泌性中耳炎（SOM）的临床疗效及并发症情况。方法 选取2020年1月-2023年6月上栗县人民医院眼耳鼻喉科收治的60例SOM患者，经随机数字表法分为对照组（31例）和观察组（29例）。对照组行常规保守治疗，观察组则应用内镜下TBI治疗，比较两组临床疗效、咽鼓管功能[捏鼻鼓气（Valsalva）法评分、咽鼓管功能障碍７项问卷（ETDQ-7）]、耳鸣症状[耳鸣评价量表（TEQ）评分、耳鸣消失时间]、听力水平（听力检测值、耳闭消失时间）、并发症。结果 观察组治疗有效率为96.55%，高于对照组的77.42%（P＜0.05）。两组术后4个月Valsalva、ETDQ-7评分低于术前，且观察组Valsalva、ETDQ-7评分低于对照组（P＜0.05）；两组TEQ评分低于术前，且观察组TEQ评分低于对照组，耳鸣消失时间短于对照组（P＜0.05）；两组听力检测值低于术前，且观察组听力检测值低于对照组，耳闭消失时间短于对照组（P＜0.05）。观察组并发症发生率为20.69%，高于对照组的3.23%（P＜0.05）。结论 内镜下TBI治疗SOM效果肯定，可改善患者咽鼓管功能，加速耳鸣消退，减轻或消除耳闭症状以提高听力水平，但存在一定并发症风险。
Abstract:
Objective To study the clinical efficacy and complications of endoscopic tympanostomy tube insertion (TBI) in the treatment of secretory otitis media (SOM).Methods Sixty SOM patients admitted to the Department of Ophthalmology, Otorhinolaryngology, Shangli County People’s Hospital from January 2020 to June 2023 were selected and divided into control group (31 patients) and observation group (29 patients) by random number table method. The control group was treated with routine conservative treatment, while the observation group was treated with endoscopic TBI. The clinical efficacy, eustachian tube function [Valsalva score, Eustachian tube dysfunction questionnaire (ETDQ-7)], tinnitus symptoms [Tinnitus Evaluation Questionnaire (TEQ) score, tinnitus disappearance time], hearing level (hearing test value, ear closure disappearance time) and complications were compared between the two groups.Results The effective rate of treatment in the observation group was 96.55%, which was higher than 77.42% in the control group (P<0.05). The scores of Valsalva and ETDQ-7 in the two groups at 4 months after operation were lower than those before operation, and the scores of Valsalva and ETDQ-7 in the observation group were lower than those in the control group (P<0.05). The TEQ score of the two groups were lower than those before operation, and the TEQ score of the observation group was lower than that of the control group, and the disappearance time of tinnitus was shorter than that of the control group (P<0.05). The hearing test values of the two groups were lower than those before operation, and the hearing test value of the observation group was lower than that of the control group, and the disappearance time of ear closure was shorter than that of the control group (P<0.05). The incidence of complications in the observation group was 20.69%, which was higher than 3.23% in the control group (P<0.05).Conclusion Endoscopic TBI is effective in the treatment of SOM, which can improve the function of eustachian tube, accelerate the regression of tinnitus, reduce or eliminate the symptoms of ear closure to improve the hearing level, but there is a certain risk of complications.

参考文献/References:

[1]周红艳.孟鲁司特钠联合鼻内镜下同步腺样体切除及鼓膜置管术对分泌性中耳炎患儿听力的影响[J].中国妇幼保健,2023,38(8):1427-1430.[2]李毅,刘宇,李钢.鼓室内注射地塞米松和盐酸氨溴索治疗分泌性中耳炎[J].西北药学杂志,2023,38(2):198-202.[3]聂雷,李慧,赵曼,等.鼓膜置管术与腺样体切除术治疗儿童分泌性中耳炎的效果及复发的影响因素分析[J].河北医药,2023,45(4):522-526.[4]Abdelrazik M,Ghalab A,Elsayed M.Different Methods of Treatment of Secretory Otitis Media in Children; A Meta-Analytical Study[J].Egypts Presidential Specialized Council for Education and Scientific Research,2021,6(1):109-113.[5]李维阁.腺样体切除联合耳内镜下鼓膜置管或鼓膜穿刺治疗儿童分泌性中耳炎的对照分析[J].贵州医药,2022,46(3):368-369.[6]李秋焕,姜子刚,田晓斌,等.成人慢性复发性分泌性中耳炎采用咽鼓管球囊扩张联合鼓膜切开置管术的疗效观察[J].临床耳鼻咽喉头颈外科杂志,2021,35(12):1073-1077,1084.[7]邱志利,蒋晓平.咽鼓管球囊扩张术联合鼓膜置管治疗难治性分泌性中耳炎的疗效分析[J].中国中西医结合耳鼻咽喉科杂志,2021,29(4):259-262,286.[8]李谊,张素娜,赵颜颜,等.咽鼓管球囊扩张联合红光照射治疗顽固性分泌性中耳炎疗效观察[J].人民军医,2021,64(7):647-649.[9]金玮,陈红.鼓膜置管、曲安奈德局部灌注联合咽鼓管球囊扩张术治疗分泌性中耳炎的临床疗效观察[J].医学综述,2021,27(9):1847-1851.[10]蔡彬林,瞿秀,瞿春林.分泌性中耳炎患者关于促炎作用、液体平衡、血管通透性及氧化应激的变化分析[J].海南医学院学报,2019,25(10):788-791.[11]莫贤海,龙增勇,韦飞虎,等.鼓膜置管术对分泌性中耳炎患儿术后生活质量的影响[J].现代生物医学进展,2020,20(10):1905-1908.[12]高燕,马静,明澄,等.咽鼓管球囊扩张联合鼓膜置管术在儿童复发性分泌性中耳炎中的疗效[J].昆明医科大学学报,2020,41(4):132-136.[13]雷雳,王丹妮,郝欣平,等.鼓膜置管术治疗放射性分泌性中耳炎的疗效及其并发症处理[J].临床耳鼻咽喉头颈外科杂志,2020,34(4):334-337.[14]柴雪绵,王盛杰,施陈克.耳内镜下鼓膜置管术联合盐酸左氧氟沙星滴耳液治疗婴幼儿分泌性中耳炎的效果及安全性分析[J].中国妇幼保健,2019,34(23):5546-5548.[15]张伟强,刘稳,李培华,等.咽鼓管冠脉球囊扩张联合鼓膜置管治疗复发性分泌性中耳炎[J].中国耳鼻咽喉颅底外科杂志,2019,25(4):419-422.[16]熊素芳,王美荣,江恒,等.咽鼓管球囊扩张联合鼓膜置管术治疗慢性分泌性中耳炎的疗效观察[J].听力学及言语疾病杂志,2019,27(3):326-328.[17]洪晓林,阮冠鑫,梁友情,等.经耳内镜下鼓膜置管联合鼻内镜下腺样体切除治疗儿童分泌性中耳炎的疗效观察[J].贵州医药,2018,42(10):1250-1251.[18]李建玲,赵广辉,刘杰.耳内镜下鼓膜置管术与鼓膜穿刺术治疗分泌性中耳炎疗效对比研究[J].陕西医学杂志,2018,47(8):1023-1025,1035.[19]许智华,张星,冀洁,等.鼓膜置管术治疗儿童分泌性中耳炎的疗效及术后复发的影响因素分析[J].中国优生与遗传杂志,2022,30(8):1434-1439.[20]殷显辉,邹剑.耳镜下鼓膜置管术联合腺样体切除术治疗儿童分泌性中耳炎的疗效[J].医学临床研究,2019,36(6):1081-1083.[21]丁曌冉,蒋成义,王伟,等.耳内镜下鼓膜修补手术治疗湿耳期中耳炎的临床疗效分析[J].中华全科医学,2021,19(2):212-216.

相似文献/References:

[1]刘光华.不同鼓室图对分泌性中耳炎转归的影响[J].医学信息,2018,31(03):107.[doi:10.3969/j.issn.1006-1959.2018.03.035]
　LIU Guang-hua.Effect of Different Tympanograms on the Outcome of Secretory Otitis Media[J].Journal of Medical Information,2018,31(22):107.[doi:10.3969/j.issn.1006-1959.2018.03.035]
[2]李 亮,沈 蓓.分泌性中耳炎的外科治疗现状[J].医学信息,2018,31(10):44.[doi:10.3969/j.issn.1006-1959.2018.10.014]
　LI Liang,SHEN Bei.Status of Surgical Treatment of Secretory Otitis Media[J].Journal of Medical Information,2018,31(22):44.[doi:10.3969/j.issn.1006-1959.2018.10.014]
[3]陶雪莹,岑 超,何俐莹.盐酸氨溴索联合通窍鼻炎颗粒治疗幼儿分泌性中耳炎的临床效果[J].医学信息,2019,32(20):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
　TAO Xue-ying,CEN Chao,HE Li-ying.Clinical Effect of Ambroxol Hydrochloride Combined with Tongqiao Rhinitis Granules in the Treatment of Secretory Otitis Media in Children[J].Journal of Medical Information,2019,32(22):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
[4]钟伦坤,胡文健,周兴玮,等.清窍胶囊对分泌性中耳炎大鼠Th17、Treg细胞及炎性因子的影响[J].医学信息,2021,34(17):75.[doi:10.3969/j.issn.1006-1959.2021.17.019]
　ZHONG Lun-kun,HU Wen-jian,ZHOU Xing-wei,et al.Effect of Qingqiao Capsule on Th17,Treg Cells and Inflammatory Factors in Rats with Secretory Otitis Media[J].Journal of Medical Information,2021,34(22):75.[doi:10.3969/j.issn.1006-1959.2021.17.019]
[5]刘 柯,赵兴泉,钟 渠.细胞因子在分泌性中耳炎相关免疫机制中的研究进展[J].医学信息,2022,35(12):73.[doi:10.3969/j.issn.1006-1959.2022.12.017]
　LIU Ke,ZHAO Xing-quan,ZHONG Qu.Research Progress of Cytokines in Secretory Otitis Media Related Immune Mechanism[J].Journal of Medical Information,2022,35(22):73.[doi:10.3969/j.issn.1006-1959.2022.12.017]

更新日期/Last Update: 1900-01-01